Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Zevra Therapeutics
AddedFeb 20, 2024
UpdatedJun 18, 2026
Zevra Therapeutics

Zevra Therapeutics

Public

Zevra Therapeutics, a biopharmaceutical firm, innovates safer therapies for pain, ADHD, and CNS diseases using its proprietary LAT approach.

HQ
Orlando, FL, US
Founded
2006
Overview
Compare
Fundraising
Employees
Website

Zevra Therapeutics, founded to innovate in the biopharmaceutical sector, focuses on developing safer therapies for pain, ADHD, and central nervous system (CNS) diseases. Utilizing its proprietary Ligand Activated Therapy (LAT) approach, Zevra aims to create abuse-resistant opioid pain relievers and improve existing drugs to expedite development timelines. Their product portfolio includes Olpruva® and Azstarys®, targeting specific medical needs within their market focus.

Notable figures affiliated with Zevra include its leadership team and board of directors, who bring extensive industry experience. The company has achieved significant milestones, such as the acquisition of Acer Therapeutics, expanding its therapeutic reach. Zevra's impact is marked by its commitment to addressing unmet medical needs through innovative drug development, contributing to advancements in pain management and CNS disease treatment.

Zevra Therapeutics - Similar Companies

Trevena logo

Trevena

Latigo Biotherapeutics logo

Latigo Biotherapeutics

latigobio.com

Zena Therapeutics logo

Zena Therapeutics

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Azevan Pharmaceuticals logo

Azevan Pharmaceuticals

azevan.com

Trigemina logo

Trigemina

Lyndra logo

Lyndra

lyndra.com

Zocere logo

Zocere

zocere.com

Aztherapies logo

Aztherapies

Concentric Analgesics logo

Concentric Analgesics

Tremeau Pharmaceuticals logo

Tremeau Pharmaceuticals

Eva Medtec logo

Eva Medtec

Azora Therapeutics logo

Azora Therapeutics

Aquestive Therapeutics logo

Aquestive Therapeutics

aquestive.com

Zenobia Therapeutics logo

Zenobia Therapeutics

Zevra Therapeutics - Quick Facts

Who are Zevra Therapeutics' competitors?

Companies similar to Zevra Therapeutics include Trevena, Latigo Biotherapeutics, Zena Therapeutics and NeuroTherapeutics Pharma.

When was Zevra Therapeutics founded?

Zevra Therapeutics was founded in 2006.

Where is Zevra Therapeutics' headquarters located?

Zevra Therapeutics' headquarters is located in Orlando, FL, US.

When was Zevra Therapeutics' last funding round?

Zevra Therapeutics' most recent funding round was for $78M (USD) in December 2019.

How much has Zevra Therapeutics raised to-date?

As of Dec 1, 2019, Zevra Therapeutics has raised a total of $153.8M (USD).

How many employees does Zevra Therapeutics have?

Zevra Therapeutics has 40 employees as of Feb 5, 2024.

Zevra Therapeutics - Classification

Industry
  • Therapeutics
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pain Relief
  • Therapeutics
Tags
  • Biotech
  • Healthcare
  • Healthtech
Unique IDs
  • ein: 205894398
  • secCik: 0001434647
  • ticker: ZVRA
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research